160 related articles for article (PubMed ID: 19427369)
1. Pharmacological and autoradiographic studies on the pathophysiological role of GABA(B) receptors in the dystonic hamster: pronounced antidystonic effects of baclofen after striatal injections.
Sander SE; Richter F; Raymond R; Diwan M; Lange N; Nobrega JN; Richter A
Neuroscience; 2009 Aug; 162(2):423-30. PubMed ID: 19427369
[TBL] [Abstract][Full Text] [Related]
2. Effects of striatal injections of GABA(A) receptor agonists and antagonists in a genetic animal model of paroxysmal dystonia.
Hamann M; Richter A
Eur J Pharmacol; 2002 May; 443(1-3):59-70. PubMed ID: 12044793
[TBL] [Abstract][Full Text] [Related]
3. Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia.
Avchalumov Y; Sander SE; Richter F; Porath K; Hamann M; Bode C; Kirschstein T; Köhling R; Richter A
Exp Neurol; 2014 Nov; 261():677-84. PubMed ID: 25139804
[TBL] [Abstract][Full Text] [Related]
4. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dt
Hamann M; Plank J; Richter F; Bode C; Smiljanic S; Creed M; Nobrega JN; Richter A
Neuroscience; 2017 Aug; 357():84-98. PubMed ID: 28596119
[TBL] [Abstract][Full Text] [Related]
5. Effects of pharmacological entopeduncular manipulations on idiopathic dystonia in the dt(sz) mutant hamster.
Hamann M; Sander SE; Kreil A; Richter A
J Neural Transm (Vienna); 2010 Jun; 117(6):747-57. PubMed ID: 20454986
[TBL] [Abstract][Full Text] [Related]
6. Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant.
Sander SE; Richter A
Eur J Pharmacol; 2007 Jun; 563(1-3):102-8. PubMed ID: 17349621
[TBL] [Abstract][Full Text] [Related]
7. Striatal microinjections of nitric oxide synthase inhibitors and L-arginine fail to exert effects on paroxysmal dystonia in the dtsz mutant.
Sander SE; Richter A
Neurosci Lett; 2006 May; 398(1-2):97-101. PubMed ID: 16423462
[TBL] [Abstract][Full Text] [Related]
8. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model.
Rehders JH; Löscher W; Richter A
Neuroscience; 2000; 97(2):267-77. PubMed ID: 10799758
[TBL] [Abstract][Full Text] [Related]
9. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia.
Gernert M; Hamann M; Bennay M; Löscher W; Richter A
J Neurosci; 2000 Sep; 20(18):7052-8. PubMed ID: 10995851
[TBL] [Abstract][Full Text] [Related]
10. Effects of locally administered pentylenetetrazole on nigral single unit activity and severity of dystonia in a genetic model of paroxysmal dystonia.
Fedrowitz M; Hamann M; Rehders JH; Richter A; Gernert M
J Neurosci Res; 2002 Jun; 68(5):595-603. PubMed ID: 12111849
[TBL] [Abstract][Full Text] [Related]
11. Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.
Fredow G; Löscher W
Eur J Pharmacol; 1991 Jan; 192(2):207-19. PubMed ID: 1851702
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine receptor binding and cholinergic interneuron density are unaltered in a genetic animal model of primary paroxysmal dystonia.
Hamann M; Raymond R; Varughesi S; Nobrega JN; Richter A
Brain Res; 2006 Jul; 1099(1):176-82. PubMed ID: 16764832
[TBL] [Abstract][Full Text] [Related]
13. Antidystonic efficacy of nitric oxide synthase inhibitors in a rodent model of primary paroxysmal dystonia.
Richter A; Löschmann PA; Löscher W
Br J Pharmacol; 2000 Nov; 131(5):921-6. PubMed ID: 11053212
[TBL] [Abstract][Full Text] [Related]
14. Decreased adenosine receptor binding in dystonic brains of the dt(sz) mutant.
Nobrega JN; Barlow KL; Raymond R; Richter A
Neuroscience; 2005; 134(1):33-8. PubMed ID: 15961243
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic and pharmacological studies on the role of dopamine D3 receptors in genetically dystonic (dt(sz)) hamsters.
Sander SE; Raymond R; Nobrega JN; Richter A
Pharmacol Biochem Behav; 2010 Aug; 96(2):136-40. PubMed ID: 20451545
[TBL] [Abstract][Full Text] [Related]
16. Effects of the kynurenine 3-hydroxylase inhibitor Ro 61-8048 after intrastriatal injections on the severity of dystonia in the dt sz mutant.
Hamann M; Sander SE; Richter A
Eur J Pharmacol; 2008 May; 586(1-3):156-9. PubMed ID: 18353306
[TBL] [Abstract][Full Text] [Related]
17. Changes in dynorphin immunoreactivity but unaltered density of enkephalin immunoreactive neurons in basal ganglia nuclei of genetically dystonic hamsters.
Kreil A; Hamann M; Sander SE; Richter A
Synapse; 2011 Nov; 65(11):1196-203. PubMed ID: 21638337
[TBL] [Abstract][Full Text] [Related]
18. The α2β3γ2 GABA
Spröte C; Richter F; Bauer A; Gerstenberger J; Richter A
Eur J Pharmacol; 2016 Nov; 791():655-658. PubMed ID: 27693801
[TBL] [Abstract][Full Text] [Related]
19. The carbonic anhydrase inhibitor acetazolamide exerts antidystonic effects in the dt(sz) mutant hamster.
Richter A; Hamann M
Eur J Pharmacol; 2004 Oct; 502(1-2):105-8. PubMed ID: 15464095
[TBL] [Abstract][Full Text] [Related]
20. Extracellular amino acid levels in the striatum of the dt(sz) mutant, a model of paroxysmal dystonia.
Hamann M; Sohr R; Morgenstern R; Richter A
Neuroscience; 2008 Nov; 157(1):188-95. PubMed ID: 18824218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
